                         SEQUENCE LISTING

<110>  NUVOBIO CORPORATION
 
<120>  PEPTIDE-DERIVED THERAPEUTICS TARGETING KDM5C FOR THE TREATMENT OF 
       CANCER

<130>  3810-104PCT

<150>  62/818,793
<151>  2019-03-15

<160>  66    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  1

Thr Asp Thr Thr Lys Thr His His His 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  2

Thr Asp Thr Gln Lys Thr His His His 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  3

Thr Asp Thr Asn Lys Thr His His His 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  4

Thr Glu Asp Ser Lys Thr His His His 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  5

Thr Glu Asp Gln Lys Thr His His His 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  6

Thr Thr Gln Ser Lys Thr His His His 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  7

Thr Asp Thr Ser Lys Thr His His His 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  8

Thr Glu Asp Thr Lys Thr His His His 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  9

Thr Glu Glu Gln Lys Thr His His His 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  10

Ser Asp Gln Gln Lys Thr His His His 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  11

Thr Thr Gln Gln Lys Thr His His His 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  12

Ser Asp Gln Thr Lys Thr His His His 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  13

Thr Asp Asp Gln Lys Thr His His His 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  14

Thr Glu Glu Asn Lys Thr His His His 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  15

Thr Glu Glu Ser Lys Thr His His His 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  16

Thr Thr Gln Thr Lys Thr His His His 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  17

Thr Asp Ser Thr Lys Thr His His His 
1               5                   


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  18

Ser Glu Thr Gln Lys Thr His His His 
1               5                   


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  19

Ser Glu Thr Ser Lys Thr His His His 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  20

Thr Asp Asp Asn Lys Thr His His His 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  21

Thr Asp Thr Thr Xaa Thr His His His 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  22

Thr Asp Thr Gln Xaa Thr His His His 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  23

Thr Asp Thr Asn Xaa Thr His His His 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  24

Thr Glu Asp Ser Xaa Thr His His His 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  25

Thr Glu Asp Gln Xaa Thr His His His 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  26

Thr Thr Gln Ser Xaa Thr His His His 
1               5                   


<210>  27
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  27

Thr Asp Thr Ser Xaa Thr His His His 
1               5                   


<210>  28
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  28

Thr Glu Asp Thr Xaa Thr His His His 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  29

Thr Glu Glu Gln Xaa Thr His His His 
1               5                   


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  30

Ser Asp Gln Gln Xaa Thr His His His 
1               5                   


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  31

Thr Thr Gln Gln Xaa Thr His His His 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  32

Ser Asp Gln Thr Xaa Thr His His His 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  33

Thr Asp Asp Gln Xaa Thr His His His 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  34

Thr Glu Glu Asn Xaa Thr His His His 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  35

Thr Glu Glu Ser Xaa Thr His His His 
1               5                   


<210>  36
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  36

Thr Thr Gln Thr Xaa Thr His His His 
1               5                   


<210>  37
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  37

Thr Asp Ser Thr Xaa Thr His His His 
1               5                   


<210>  38
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  38

Ser Glu Thr Gln Xaa Thr His His His 
1               5                   


<210>  39
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  39

Ser Glu Thr Ser Xaa Thr His His His 
1               5                   


<210>  40
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  norLeucine (Nle)

<400>  40

Thr Asp Asp Asn Xaa Thr His His His 
1               5                   


<210>  41
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  41

Arg Thr Lys Gln Thr Ala Arg Lys Ser Thr Gly Gly 
1               5                   10          


<210>  42
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  42

Arg Thr Asn Gln Thr Ala Arg Lys Ser Thr Gly Gly 
1               5                   10          


<210>  43
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C

<400>  43

Gly Ala Lys Arg His Arg Lys Val Leu Arg Asp Asn Ile 
1               5                   10              


<210>  44
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide binding to KDM5C


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa can be any naturally occurring amino acid

<400>  44

Gly Ala Lys Arg His Arg Xaa Val Leu Arg Asp Asn Ile 
1               5                   10              


<210>  45
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT48-60

<400>  45

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  46
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Penetratin, pAntp(43-58)

<400>  46

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  47
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Penetratin, pAntp(43-58)

<400>  47

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  48
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DPV1047

<400>  48

Val Lys Arg Gly Leu Lys Leu Arg His Val Arg Pro Arg Val Thr Arg 
1               5                   10                  15      


Met Asp Val 
            


<210>  49
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PR9

<400>  49

Phe Phe Leu Ile Pro Lys Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


<210>  50
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mut6DPT (CPP)

<400>  50

Arg Arg Trp Arg Arg Trp Arg Arg Trp Arg Arg 
1               5                   10      


<210>  51
<211>  27
<212>  PRT
<213>  Artificial Seequence

<220>
<223>  MPG

<400>  51

Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210>  52
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pep-1

<400>  52

Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210>  53
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  pVEC

<400>  53

Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210>  54
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ARF(1-22)

<400>  54

Met Val Arg Arg Phe Leu Val Thr Leu Arg Ile Arg Arg Ala Cys Gly 
1               5                   10                  15      


Pro Pro Arg Val Arg Val 
            20          


<210>  55
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  BPrPr(1-28)

<400>  55

Met Val Lys Ser Lys Ile Gly Ser Trp Ile Leu Val Leu Phe Val Ala 
1               5                   10                  15      


Met Trp Ser Asp Val Gly Leu Cys Lys Lys Arg Pro 
            20                  25              


<210>  56
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MAP

<400>  56

Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210>  57
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Transportan

<400>  57

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  58
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  p28

<400>  58

Leu Ser Thr Ala Ala Asp Met Gln Gly Val Val Thr Asp Gly Met Ala 
1               5                   10                  15      


Ser Gly Leu Asp Lys Asp Tyr Leu Lys Pro Asp Asp 
            20                  25              


<210>  59
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VT5

<400>  59

Asp Pro Lys Gly Asp Pro Lys Gly Val Thr Val Thr Val Thr Val Thr 
1               5                   10                  15      


Val Thr Gly Lys Gly Asp Pro Lys Pro Asp 
            20                  25      


<210>  60
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Bac 7 (Bac 1-24)

<400>  60

Arg Arg Ile Arg Pro Arg Pro Pro Arg Leu Pro Arg Pro Arg Pro Arg 
1               5                   10                  15      


Pro Leu Pro Phe Pro Arg Pro Gly 
            20                  


<210>  61
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C105Y

<400>  61

Cys Ser Ile Pro Pro Glu Val Lys Phe Asn Lys Pro Phe Val Tyr Leu 
1               5                   10                  15      


Ile 
    


<210>  62
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PFVYLI

<400>  62

Pro Phe Val Tyr Leu Ile 
1               5       


<210>  63
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pep-7

<400>  63

Ser Asp Leu Trp Glu Met Met Met Val Ser Leu Ala Cys Gln Tyr 
1               5                   10                  15  


<210>  64
<211>  765
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  The sequence of recombinant KDM5C

<400>  64

Met Glu Pro Gly Ser Asp Asp Phe Leu Pro Pro Pro Glu Cys Pro Val 
1               5                   10                  15      


Phe Glu Pro Ser Trp Ala Glu Phe Arg Asp Pro Leu Gly Tyr Ile Ala 
            20                  25                  30          


Lys Ile Arg Pro Ile Ala Glu Lys Ser Gly Ile Cys Lys Ile Arg Pro 
        35                  40                  45              


Pro Ala Asp Trp Gln Pro Pro Phe Ala Val Glu Val Asp Asn Phe Arg 
    50                  55                  60                  


Phe Thr Pro Arg Ile Gln Arg Leu Asn Glu Leu Glu Ala Gln Thr Arg 
65                  70                  75                  80  


Val Lys Leu Asn Tyr Leu Asp Gln Ile Ala Lys Phe Trp Glu Ile Gln 
                85                  90                  95      


Gly Ser Ser Leu Lys Ile Pro Asn Val Glu Arg Arg Ile Leu Asp Leu 
            100                 105                 110         


Tyr Ser Leu Ser Lys Ile Val Val Glu Glu Gly Gly Tyr Glu Ala Ile 
        115                 120                 125             


Cys Lys Asp Arg Arg Trp Ala Arg Val Ala Gln Arg Leu Asn Tyr Pro 
    130                 135                 140                 


Pro Gly Lys Asn Ile Gly Ser Leu Leu Arg Ser His Tyr Glu Arg Ile 
145                 150                 155                 160 


Val Tyr Pro Tyr Glu Met Tyr Gln Ser Gly Ala Asn Leu Val Gln Cys 
                165                 170                 175     


Asn Thr Arg Pro Phe Asp Asn Glu Glu Lys Asp Lys Glu Tyr Lys Pro 
            180                 185                 190         


His Ser Ile Pro Leu Arg Gln Ser Val Gln Pro Ser Lys Phe Asn Ser 
        195                 200                 205             


Tyr Gly Arg Arg Ala Lys Arg Leu Gln Pro Asp Pro Glu Pro Thr Glu 
    210                 215                 220                 


Glu Asp Ile Glu Lys Asn Pro Glu Leu Lys Lys Leu Gln Ile Tyr Gly 
225                 230                 235                 240 


Ala Gly Pro Lys Met Met Gly Leu Gly Leu Met Ala Lys Asp Lys Thr 
                245                 250                 255     


Leu Arg Lys Lys Asp Lys Glu Gly Pro Glu Cys Pro Pro Thr Val Val 
            260                 265                 270         


Val Lys Glu Glu Leu Gly Gly Asp Val Lys Val Glu Ser Thr Ser Pro 
        275                 280                 285             


Lys Thr Phe Leu Glu Ser Lys Glu Glu Leu Ser His Ser Pro Glu Pro 
    290                 295                 300                 


Cys Thr Lys Met Thr Met Arg Leu Arg Arg Asn His Ser Asn Ala Gln 
305                 310                 315                 320 


Phe Ile Glu Ser Tyr Val Cys Arg Met Cys Ser Arg Gly Asp Glu Asp 
                325                 330                 335     


Asp Lys Leu Leu Leu Cys Asp Gly Cys Asp Asp Asn Tyr His Ile Phe 
            340                 345                 350         


Cys Leu Leu Pro Pro Leu Pro Glu Ile Pro Lys Gly Val Trp Arg Cys 
        355                 360                 365             


Pro Lys Cys Val Met Ala Glu Cys Lys Arg Pro Pro Glu Ala Phe Gly 
    370                 375                 380                 


Phe Glu Gln Ala Thr Arg Glu Tyr Thr Leu Gln Ser Phe Gly Glu Met 
385                 390                 395                 400 


Ala Asp Ser Phe Lys Ala Asp Tyr Phe Asn Met Pro Val His Met Val 
                405                 410                 415     


Pro Thr Glu Leu Val Glu Lys Glu Phe Trp Arg Leu Val Asn Ser Ile 
            420                 425                 430         


Glu Glu Asp Val Thr Val Glu Tyr Gly Ala Asp Ile His Ser Lys Glu 
        435                 440                 445             


Phe Gly Ser Gly Phe Pro Val Ser Asp Ser Lys Arg His Leu Thr Pro 
    450                 455                 460                 


Glu Glu Glu Glu Tyr Ala Thr Ser Gly Trp Asn Leu Asn Val Met Pro 
465                 470                 475                 480 


Val Leu Glu Gln Ser Val Leu Cys His Ile Asn Ala Asp Ile Ser Gly 
                485                 490                 495     


Met Lys Val Pro Trp Leu Tyr Val Gly Met Val Phe Ser Ala Phe Cys 
            500                 505                 510         


Trp His Ile Glu Asp His Trp Ser Tyr Ser Ile Asn Tyr Leu His Trp 
        515                 520                 525             


Gly Glu Pro Lys Thr Trp Tyr Gly Val Pro Ser Leu Ala Ala Glu His 
    530                 535                 540                 


Leu Glu Glu Val Met Lys Lys Leu Thr Pro Glu Leu Phe Asp Ser Gln 
545                 550                 555                 560 


Pro Asp Leu Leu His Gln Leu Val Thr Leu Met Asn Pro Asn Thr Leu 
                565                 570                 575     


Met Ser His Gly Val Pro Val Val Arg Thr Asn Gln Cys Ala Gly Glu 
            580                 585                 590         


Phe Val Ile Thr Phe Pro Arg Ala Tyr His Ser Gly Phe Asn Gln Gly 
        595                 600                 605             


Tyr Asn Phe Ala Glu Ala Val Asn Phe Cys Thr Ala Asp Trp Leu Pro 
    610                 615                 620                 


Ala Gly Arg Gln Cys Ile Glu His Tyr Arg Arg Leu Arg Arg Tyr Cys 
625                 630                 635                 640 


Val Phe Ser His Glu Glu Leu Ile Cys Lys Met Ala Ala Cys Pro Glu 
                645                 650                 655     


Lys Leu Asp Leu Asn Leu Ala Ala Ala Val His Lys Glu Met Phe Ile 
            660                 665                 670         


Met Val Gln Glu Glu Arg Arg Leu Arg Lys Ala Leu Leu Glu Lys Gly 
        675                 680                 685             


Ile Thr Glu Ala Glu Arg Glu Ala Phe Glu Leu Leu Pro Asp Asp Glu 
    690                 695                 700                 


Arg Gln Cys Ile Lys Cys Lys Thr Thr Cys Phe Leu Ser Ala Leu Ala 
705                 710                 715                 720 


Cys Tyr Asp Cys Pro Asp Gly Leu Val Cys Leu Ser His Ile Asn Asp 
                725                 730                 735     


Leu Cys Lys Cys Ser Ser Ser Arg Gln Tyr Leu Arg Tyr Arg Tyr Thr 
            740                 745                 750         


Leu Asp Glu Leu Pro Ala Met Leu His Lys Leu Lys Val 
        755                 760                 765 


<210>  65
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  T or S

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D, E or I

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  T, D or Q

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Q, S, N or T

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  K or Nle

<400>  65

Xaa Xaa Xaa Xaa Xaa Thr His His His 
1               5                   


<210>  66
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  KDM5C binding peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  K, G, L, Q, V, E, H or I

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  I, L, V or D

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  L, M, V, F or S

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  V or K

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  V, G, R, L, K, F, H, T, A, P, I or N

<400>  66

Thr Xaa Xaa Xaa Xaa Xaa His His His 
1               5                   


